PTK2 and prostate carcinoma: In prostate cancer cells, it was also recently reported that the negative impact of KAI1 on epithelial-to-mesenchymal transition was due to its interactions with the integrins α3ß1 and α5ß1, its interference with integrin activation, and, consequently, its hinderance of integrin signaling via FAK.